Transactions
Dec. 4, 2001
Heller Ehrman: SAN FRANCISCO BIOTECH COMPANY NABS GENOMICA
South San Francisco-based Exelixis Inc. has agreed to acquire Boulder, Colo.-based Genomica Corp. in a stock transaction valued at $110 million.
Exelixis is a biotechnology company that focuses its research on the discovery and development of drugs for human disease treatment. The company's drug research offerings include treatments for diabetes, obesity, Alzheimer's diseas...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In